The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
The OncoAlert Newsletter is now out for June 23-29, 2023
Mohamad Mohty, MD, PhD, highlights key takeaways from the 50th Annual EMBT Meeting, focusing on ongoing efforts within the GVHD treatment arena.
David J. Andorsky, MD, discussed real-world findings from a study which evaluated BTK inhibitors in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
A Roswell Park-led team uncovers beneficial effects of combining VEGFR-targeting TKIs with checkpoint inhibitors in new research.
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.
The SGO BRIDGES Research Initiative is a new, longitudinal clinical trials workshop for early career investigators with the aim of developing the next generation of…
An abstract is unavailable.
Cancer-associated fibroblasts (CAFs) exhibit spatial and functional diversity. Here, Niu et al. unveil SETD2’s function in lipid metabolism and CAF heterogeneity in pancreatic ductal adenocarcinoma. SETD2…
Anne Chiang, MD, PhD, discusses understanding the heterogeneity of SCLC to determine which patients will respond to targeted therapy.
A nipple delay is a procedure, typically used with a nipple-sparing mastectomy, that aims to save the nipple during breast cancer surgery.
It’s been inspiring – and humbling – to get to know the 40 young leaders in this year’s class. I recommend we all keep an…